SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001410578-23-001384
Filing Date
2023-05-30
Accepted
2023-05-30 16:15:46
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 6-K cvac-20230331x6k.htm   iXBRL 6-K 107042
2 EX-99.1 cvac-20230331xex99d1.htm   iXBRL EX-99.1 656121
3 EX-99.2 cvac-20230331xex99d2.htm EX-99.2 247035
4 GRAPHIC cvac-20230331xex99d1001.jpg GRAPHIC 9817
  Complete submission text file 0001410578-23-001384.txt   5628773

Data Files

Seq Description Document Type Size
5 EX-101.SCH cvac-20230331.xsd EX-101.SCH 98104
6 EX-101.CAL cvac-20230331_cal.xml EX-101.CAL 73606
7 EX-101.DEF cvac-20230331_def.xml EX-101.DEF 319964
8 EX-101.LAB cvac-20230331_lab.xml EX-101.LAB 673546
9 EX-101.PRE cvac-20230331_pre.xml EX-101.PRE 471856
64 EXTRACTED XBRL INSTANCE DOCUMENT cvac-20230331x6k_htm.xml XML 656813
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39446 | Film No.: 23976585
SIC: 2834 Pharmaceutical Preparations